Not a good buy right now for an impatient buyer: price ($68.68) is sitting near key pivot support (~$68.28) but momentum is still bearish (MACD worsening), and near-term pattern stats lean down over the next day.
Upside exists on a 1-month view (pattern study suggests +7.28% potential), but without a proprietary buy signal, the risk of getting a worse fill soon (next support ~$62.48) is meaningful.
Wall Street price targets are mixed and skew below the current price outside of Citi; that reduces near-term “easy” upside.
Trend/Momentum: Bearish short-term—MACD histogram (-0.573) is below zero and negatively expanding, indicating downside momentum still building.
RSI: RSI(6) at ~29.5 is near oversold territory, consistent with a post-earnings selloff that may be due for a bounce, but oversold can persist when MACD is deteriorating.
Moving averages: Converging MAs suggest the stock may be transitioning after the sharp drop, but not yet confirming an uptrend.
Key levels: Pivot support ~68.28 is being tested (current ~68.68). If it breaks, next supports are ~62.48 (S1) then ~58.90 (S2). Upside resistances: ~74.07 (R1) and ~77.65 (R2).
Quant/pattern read: Similar candlestick-pattern basket implies 80% odds of about -2.19% next day, modest +1.17% next week, and +7.28% next month—near-term chop/down risk with better medium-term rebound potential.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Very low put/call ratios (OI and volume) indicate bullish skew/limited demand for downside protection.
Activity: Volume is extremely elevated vs 30-day average (~805% of average), signaling heavy post-event speculation.
Volatility: 30D IV (21.49) is below HV (24.49), but IV percentile is high (~78.88), implying options are relatively “rich” versus their recent distribution even after the move.
Takeaway: Options market looks risk-on/bullish, but with elevated IV and huge volume, it also reflects post-earnings uncertainty and fast-money trading rather than stable conviction.
Technical Summary
Sell
7
Buy
5
Positive Catalysts
results showed solid top-line growth and continued digital scale: revenue +10.42% YoY to ~$802.3M; EPS +6.76% YoY.
Neutral/Negative Catalysts
Post-earnings reset: stock reaction was sharply negative (news notes -10% to -17.5% around Q4), suggesting investors disliked some aspect of outlook/expectations even with headline beats.
Technical pressure: MACD is still deteriorating; risk of a further leg down toward ~$62.5 support remains.
Analyst target friction: multiple recent targets cluster at $60–$68 (at/under current price), limiting near-term “target-based” upside support.
No noted insider/hedge fund accumulation signal: trading trends show insiders and hedge funds are Neutral (no strong sponsorship signal).
Financial Performance
Latest quarter: 2025/Q4.
Growth: Revenue $802.314M (+10.42% YoY); Net income $129.838M (+4.94% YoY); EPS $0.79 (+6.76% YoY) — healthy growth, but earnings growth lagged revenue (suggesting some cost/investment pressure).
Profitability: Gross margin 51.63% (+2.08% YoY), a constructive improvement.
Overall: Fundamentals look solid (growth + margin improvement), but the market’s sharp selloff implies expectations/outlook were the real issue, not the quarter itself.
Congress/politicians: No recent congress trading data available (no signal from that channel).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Price targets have been raised into 2026, but many firms remain Neutral/Equal Weight.
Guggenheim (2026-02-05): PT raised to $63 (from $57), Neutral—PT is below current price, implying limited upside in their base case.
Barclays (2026-01-20): PT $60, Equal Weight—also below current price.
Morgan Stanley (2025-12-18): PT $68, Equal Weight—roughly in line with current price.
Citi (2025-12-23 and 2025-11-13): Buy with PT raised to $81 (from $72 previously; earlier $72 from $64)—the main bullish outlier.
Wall Street pros/cons: Pros focus on durable digital subscription engine and ARPU growth; cons focus on valuation/upside being less compelling after the rebound and uncertainty around forward net adds/expectations.
Wall Street analysts forecast NYT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYT is 69.33 USD with a low forecast of 55 USD and a high forecast of 81 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast NYT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYT is 69.33 USD with a low forecast of 55 USD and a high forecast of 81 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 69.110
Low
55
Averages
69.33
High
81
Current: 69.110
Low
55
Averages
69.33
High
81
Citi
Jason Bazinet
Buy
downgrade
$81 -> $77
AI Analysis
2026-02-05
New
Reason
Citi
Jason Bazinet
Price Target
$81 -> $77
AI Analysis
2026-02-05
New
downgrade
Buy
Reason
Citi analyst Jason Bazinet lowered the firm's price target on New York Times to $77 from $81 and keeps a Buy rating on the shares.
JPMorgan
David Karnovsky
maintain
$71 -> $74
2026-02-05
New
Reason
JPMorgan
David Karnovsky
Price Target
$71 -> $74
2026-02-05
New
maintain
Reason
JPMorgan analyst David Karnovsky raised the firm's price target on New York Times to $74 from $71 and keeps an Overweight rating on the shares post the Q4 report. The company reported accelerated ad growth but with a higher expense outlook, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NYT
